Capital International Investors
Position in CRSP — CRISPR Therapeutics AG
CIK 1562230
Los Angeles, CA
Position in CRSP
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$56,455,790
-$252,559,757 QoQ
Shares Held
1,186,794
-79.9% QoQ
Ownership
1.23%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Capital International Investors holds $7,233,634,148 across 15 Biotechnology names. CRSP ranks #11 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,126,077 | $2,288,998,423 | |
| 2 | RPRX |
Royalty Pharma plc
|
35,005,736 | $1,679,225,155 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
4,158,726 | $1,235,016,860 | |
| 4 | INSM |
INSMED Inc
|
5,595,194 | $914,926,122 | |
| 5 | ASND |
Ascendis Pharma A/S
|
1,958,843 | $448,046,159 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
2,674,727 | $155,535,375 | |
| 7 | RAPP |
Rapport Therapeutics, Inc.
|
3,097,973 | $96,935,575 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,338,803 | $88,240,505 |
All Filings in CRSP
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $56,455,790 | 1,186,794 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $309,015,547 | 5,892,745 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $366,128,410 | 5,649,258 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $272,079,854 | 5,593,747 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $206,668,205 | 6,073,118 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $344,145,065 | 8,743,523 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $372,397,963 | 7,926,734 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $424,802,314 | 7,865,253 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $534,174,963 | 7,837,074 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $384,016,570 | 6,134,450 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $276,221,389 | 6,085,512 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $340,754,249 | 6,069,723 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $272,449,146 | 6,023,638 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $217,662,457 | 5,354,550 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $349,127,016 | 5,342,418 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $283,428,484 | 4,663,954 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $226,107,081 | 3,602,152 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $272,138,104 | 3,591,160 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $467,606,267 | 4,177,667 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $743,224,200 | 4,590,921 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $593,249,754 | 4,868,689 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,137,104,486 | 7,426,716 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $618,457,077 | 7,394,274 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $40,648,421 | 553,115 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $23,457,607 | 553,115 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||